Form 8-K - Current report:
SEC Accession No. 0002032966-25-000008
Filing Date
2025-03-27
Accepted
2025-03-27 07:09:03
Documents
14
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cik0002032966-20250327.htm   iXBRL 8-K 26665
2 EX-99.1 acurencorporation-exx991.htm EX-99.1 328771
  Complete submission text file 0002032966-25-000008.txt   499560

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cik0002032966-20250327.xsd EX-101.SCH 1830
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cik0002032966-20250327_lab.xml EX-101.LAB 21230
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cik0002032966-20250327_pre.xml EX-101.PRE 12068
16 EXTRACTED XBRL INSTANCE DOCUMENT cik0002032966-20250327_htm.xml XML 2747
Mailing Address 14434 MEDICAL COMPLEX DRIVE #100 TOMBALL TX 77377
Business Address 14434 MEDICAL COMPLEX DRIVE #100 TOMBALL TX 77377 800-218-7450
ACUREN CORP (Filer) CIK: 0002032966 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42524 | Film No.: 25775245
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)